Kawanishi, Japan

Fumitaka Kishimoto

This inventor holds 4 USPTO granted patents. Top assignees: Sumitomo Chemical Company, Limited, Hightech Receptor Ab, Sumitomo Pharmaceuticals Company Limited. Active years: 1990-1994.


% Patents Active = 100.0

Average Co-Inventor Count = 6.1

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Hyogo, JP (1990 - 1993)
  • Kawanishi, JP (1993 - 1994)

Company Filing History:


Years Active: 1990-1994

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Fumitaka Kishimoto: Innovator in Protein Engineering

Introduction

Fumitaka Kishimoto is a notable inventor based in Kawanishi, Japan. He has made significant contributions to the field of protein engineering, holding a total of 4 patents. His work focuses on the development of novel proteins and methods that have potential applications in various industries.

Latest Patents

One of Kishimoto's latest patents is for a gene encoding a novel protein H capable of binding to IgG. This gene, isolated from Streptococcus sp. AP1, is expressed in host cells such as E. coli to produce Protein H, which specifically binds to human IgG of all subclasses. Another significant patent involves a method for producing optically active cyclopropane carboxylic acid, showcasing his innovative approach to chemical synthesis.

Career Highlights

Throughout his career, Kishimoto has worked with prominent companies, including Sumitomo Chemical Company, Limited and Hightech Receptor Ab. His experience in these organizations has allowed him to apply his expertise in protein engineering and contribute to various research projects.

Collaborations

Kishimoto has collaborated with notable colleagues, including Hideyuki Gomi and Tatsunobu Hozumi. These partnerships have further enhanced his research and development efforts in the field.

Conclusion

Fumitaka Kishimoto's contributions to protein engineering and his innovative patents highlight his role as a significant inventor in the scientific community. His work continues to influence advancements in biotechnology and related fields.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…